@AmbrogioLab

Official account of Chiara Ambrogio´s Laboratory, https://nitter.cf/t.co/zg15HkbZoy

Joined December 2020
  • Tweets166
  • Following89
  • Followers405
7Media
AmbrogioLab retweeted
Anna Obenauf@obenaufa
6 Nov 2024
Pls RT: Are you studying the multifaceted MAPK pathway? We would love to hear about your exciting research! Abstract Deadline 👉16.12.2024 for the #virtualmeeting on "Drugging and regulating the #MAPKpathway" organised with @EACRnews with @Boehringer eacr.org/conference/boehring…
Anna Obenauf@obenaufa
4 Sep 2024
Excited to co-organize the virtual @EACRnews @Boehringer Conference: Drugging & Regulating the MAP Kinase Pathway! Submit an abstract or join us. Please RT and share with others. Details & registration: eacr.org/conference/boehring…
13
22
5,347
AmbrogioLab retweeted
CrozrX
@CrozrX
21 Oct 2024
📖 🎯 A new book! RAS Drug Discovery • Past, Present and Future 🔸️ A comprehensive overview of the state-of-the-art medicinal chemistry approaches towards targeting the formerly undruggable oncogene, KRAS. @Aiims1742 @AndresFCardonaZ @FredNatLab @Tony_Calles @chulkimMD @CentralParkWMD @StephenVLiu @BenjaminBesseMD @EricTopol @gerlach_d @ArndtVogel @RonDePinho @DrYukselUrun @DavidHongMD @CadranelJ @pashtoonkasi @ChadPecot @JacobAdashek @AmbrogioLab 🔸️ shop.elsevier.com/books/ras-…
10
1
41
3,957
I am excited for the next three days of @theNCI's RAS Initiative Symposium 2024. Today, @NCIDirector Rathmell and AACR Past President Frank McCormick kicked off this important meeting aimed at mobilizing the cancer research community to target RAS-driven cancers.
1
9
50
3,409
AmbrogioLab retweeted
Anna Obenauf@obenaufa
4 Sep 2024
Excited to co-organize the virtual @EACRnews @Boehringer Conference: Drugging & Regulating the MAP Kinase Pathway! Submit an abstract or join us. Please RT and share with others. Details & registration: eacr.org/conference/boehring…
20
2
47
12,003
Our latest publication online now! rdcu.be/dSvhN @NatureComms Amazing team work @lab_santamaria @MJNokin @BiagioRicciutMD @DrMarkAwad @NadalErnest @cereda_lab
6
2
35
1,601
Happy to share our new publication on redox sensitivities of drug persistent and resistant BRAF mutated lung cancer. @GIGA_ULiege @iecb_bordeaux @ciccancer @lab_santamaria @AmbrogioLab @frsFNRS @televie @FondationLeon cell.com/cell-reports-medici…

In vivo vulnerabilities to GPX4 and HDAC inhibitors in drug-persistent versus drug-resistant...

Nokin et al. identify two redox-related cellular states that involve an adaptive drug-tolerant stage followed by a genetic-defined resistance phase in BRAFV600E-driven lung cancer. Timely treatments...

cell.com
1
3
1
13
904
Our PREDICT project is among the 2024 ERC Proof of Concept grants! @ERC_Research #ERCPoC
European Research Council (ERC)
@ERC_Research
11 Jul 2024
📣 Out now! First results of the 2024 ERC Proof of Concept call. 100 grants – each worth €150,000 – will help ERC grantees to bridge the gap between the discoveries stemming from their frontier research and their practical application. More 👉 europa.eu/!rWx4w3
4
4
36
2,672
AmbrogioLab retweeted
EACR@EACRnews
11 Jul 2024
EACR-@Mark Foundation Postdoctoral Fellowships are awarded for a period of three years and support excellent postdoctoral researchers in laboratories throughout Europe. Is that you? 👀 Apply by 21 August: eacr.org/eacr-fellowships/ea…
5
10
1,884
Mariano Barbacid receive the Mike Price Award ⁦@EACRnews⁩ #EACR2024 👏🏻👏🏻
3
7
55
3,590
AmbrogioLab retweeted
EACR@EACRnews
7 Jun 2024
There are just a few more days left to register for our upcoming Early-Career Researchers' Conference, happening online 25-26 June! 👉 Don't miss the 12 June deadline: eacr.org/conference/earlycar…
1
14
6
22
4,569
Stunning results from @CanaudLab who just presented their case study that led to an FDA-approved drug. Thanks @unito for organizing it! #research #24May
1
1
5
897
AmbrogioLab retweeted
EACR@EACRnews
19 Apr 2024
There's not long left to wait until the EACR Congress comes to the Netherlands in June! ☀️ Don't miss the opportunity to take advantage of our discounted early registration rate to attend, available until 29 April. 2024.eacr.org/
1
7
12
1,788
Read the #CancerHallmarks Perspective— Piecing the Puzzle Together. bit.ly/3JnQwuv @AmbrogioLab @MariaPAlcolea @gemmakelly_1 @waileongtam @theLundLab @alpcorreia @CJHPhD @IngunnStromnes @DanielaQuail @ErnstAurelie @DirenaAC @ShemaEfrat @BullmanLab @Marcus_Ruscetti
2
15
32
7,077
Can you believe we got to fund 9 LS1 @ERC_research grants?!?🤩HUGE congratulations to:@clausen_lab, @Archaellum,T. Hoppe @CECAD_ , @Tampe_Lab, Y. Senis @Inserm, M. Glickman @BiologyTechnion, M. Foiani @IFOMresearch, @photosyn_Adam & @hecklab! Amazing&very diverse set of projects!
European Research Council (ERC)
@ERC_Research
11 Apr 2024
📣 Good news today for 255 outstanding research leaders who have been offered ERC Advanced Grants. The new funding, worth nearly €652 million, is part of the 🇪🇺EU’s #HorizonEurope programme. Read more 👉 europa.eu/!TkwhWc #ERCAdG #FrontierResearch @EUScienceInnov
1
3
29
4,842
Just published with the #AACR24 presentation in Attacking #KRAS Beyond G12C: Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers, by Jingjing Jiang, Zhengping Wang, Mallika Singh et al. bit.ly/3vNIQ1A #RevolutionMedicines
20
2
40
18,212
Replying to @Biagio_Ricciut
@BiagioRicciutMD from @DanaFarber is presenting today at #AACR2024 section 41 poster 18 new data on wild type KRAS amplification as a de novo oncogenic driver in NSCLC. Terrific work done in collaboration with @AmbrogioLab. @DrMarkAwad @KRASKickers
3
14
1,164
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy | Nature #AACR24 nature.com/articles/s41586-0…

Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy

Nature - RMC-7977, a compound that exhibits potent inhibition of the active states of mutant and wild-type KRAS, NRAS and HRAS variants has a strong anti-tumour effect on RAS-addicted tumours and...

nature.com
8
22
2,533
Out in @Nature concurrent with #AACR24 Two papers on biochemistry and preclinical characterization of Revolution Medicines’ RAS(ON) multiRAS inhibitor, with a focus on #PancreaticCancer @KenOliveLab @BenStanger01 @derlabunc nature.com/articles/s41586-0… nature.com/articles/s41586-0…
2
79
10
231
64,687
They define a future of cancer team science adopting “radical collaboration”—in which six “Hallmarks of Cancer Collaboration” are utilized to propel cancer teams to reach new levels of productivity and impact in the modern era. #AACR24 #AACR2024 @CD_AACR aacrjournals.org/cancerdisco…
7
1
7
4,558
Opinions of early- and mid-career investigators on the key challenges and open questions related to each of the fourteen Cancer Hallmarks. #AACR24 #AACR2024 @CD_AACR
Elizabeth McKenna@ElizSMcKenna
6 Apr 2024
Out in @CD_AACR for #AACR24 -#CancerHallmarks: Piecing the Puzzle Together @AmbrogioLab @MariaPAlcolea @gemmakelly_1 @waileongtam @theLundLab @alpcorreia @CJHPhD @IngunnStromnes @DanielaQuail @ErnstAurelie @DirenaAC @ShemaEfrat @BullmanLab @Marcus_Ruscetti doi.org/10.1158/2159-8290.CD…
5
7
1,953
Load more